ADVANCED OR METASTATIC GASTRIC ADENOCARCINOMA

Clinical trials for ADVANCED OR METASTATIC GASTRIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED OR METASTATIC GASTRIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED OR METASTATIC GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug pumitamig takes on nivolumab in stomach cancer showdown

Disease control Recruiting now

This study compares two drug combinations for people with advanced stomach, gastroesophageal junction, or esophageal cancer that hasn't been treated yet. One group gets pumitamig plus chemotherapy, the other gets nivolumab plus chemotherapy. The goal is to see which combo works b…

Matched conditions: ADVANCED OR METASTATIC GASTRIC ADENOCARCINOMA

Phase: PHASE2, PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control

Last updated Jun 28, 2026 00:00 UTC

ADVANCED OR METASTATIC GASTRIC ADENOCARCINOMA

Get alerted when new ADVANCED OR METASTATIC GASTRIC ADENOCARCINOMA trials appear

New drug pumitamig takes on nivolumab in stomach cancer showdown